Identification and characterization of a novel amphioxus dopamine D 1-like receptor

Journal of Neurochemistry

Volumn 111, Issue 1, 2009, Pages 26-36

  Burman, Chloe ^a   Reale, Vincenzina ^a   Srivastava, Deepak P ^a   Evans, Peter D ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Amphioxus; Cyclic AMP; Dopamine D1 like receptor; Expression in Chinese hamster ovary cells; Expression in Xenopus oocytes; G protein coupled receptor

Indexed keywords

BENZODIAZEPINE; DOPAMINE 1 RECEPTOR; LIGAND;

AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; CELL LINE; DNA LIBRARY; HUMAN; MAMMAL CELL; NONHUMAN; OOCYTE; PRIORITY JOURNAL; VERTEBRATE; XENOPUS;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CELL LINE, TRANSFORMED; CHORDATA, NONVERTEBRATE; CLONING, MOLECULAR; CRICETINAE; CRICETULUS; CYCLIC AMP; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; MEMBRANE POTENTIALS; MOLECULAR SEQUENCE DATA; OOCYTES; RECEPTORS, DOPAMINE D5; TRANSFECTION; XENOPUS;

BRANCHIOSTOMA FLORIDAE; BRANCHIOSTOMA LANCEOLATUM; CHORDATA; CRICETULUS GRISEUS; DEUTEROSTOMIA; INVERTEBRATA; MAMMALIA; VERTEBRATA;

EID: 70349208531     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06295.x     Document Type: Article

References (63)

1. Alberts G. L., Chio C. L. Im W. B. (2001) Allosteric modulation of the human 5-HT(7A) receptor by lipidic amphipathic compounds. Mol. Pharmacol. 60, 1349 1355.
2. Balmanno K. Cook S. J. (1999) Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 18, 3085 3097.
3. Blenau W. Baumann A. (2001) Molecular and pharmacological properties of insect biogenic amine receptors: lessons from Drosophila melanogaster and Apis mellifera. Arch. Insect Biochem. Physiol. 48, 13 38.
4. Blenau W., Erber J. Baumann A. (1998) Characterization of a dopamine D1 receptor from Apis mellifera: cloning, functional expression, pharmacology, and mRNA localization in the brain. J. Neurochem. 70, 15 23.
5. Bouvier C., Salon J. A., Johnson R. A. Civelli O. (1993) Dopaminergic activity measured in D1- and D2-transfected fibroblasts by silicon- microphysiometry. J. Recept. Res. 13, 559 571.
6. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248 254.
7. Burman C., Maqueira B., Coadwell J. Evans P. D. (2007) Eleven new putative aminergic G-protein coupled receptors from Amphioxus (Branchiostoma floridae): identification, sequence analysis and phylogenetic relationship. Invert. Neurosci. 7, 87 98.
8. Cai G., Gurdal H., Smith C., Wang H. Y. Friedman E. (1999) Inverse agonist properties of dopaminergic antagonists at the D(1A) dopamine receptor: uncoupling of the D(1A) dopamine receptor from G(s) protein. Mol. Pharmacol. 56, 989 996.
9. Candiani S., Oliveri D., Parodi M., Castagnola P. Pestarino M. (2005) AmphiD1/beta, a dopamine D1/beta-adrenergic receptor from the amphioxus Branchiostoma floridae: evolutionary aspects of the catecholaminergic system during development. Dev. Genes. Evol. 215, 631 638.
10. Cardinaud B., Sugamori K. S., Coudouel S., Vincent J. D., Niznik H. B. Vernier P. (1997) Early emergence of three dopamine D1 receptor subtypes in vertebrates. Molecular phylogenetic, pharmacological, and functional criteria defining D1A, D1B, and D1C receptors in European eel Anguilla anguilla. J. Biol. Chem. 272, 2778 2787.
11. Cardinaud B., Gilbert J. M., Liu F., Sugamori K. S., Vincent J. D., Niznik H. B. Vernier P. (1998) Evolution and origin of the diversity of dopamine receptors in vertebrates. Adv. Pharmacol. 42, 936 940.
12. Chen J., Rusnak M., Luedtke R. R. Sidhu A. (2004) D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade. J. Biol. Chem. 279, 39317 39330.
13. Clark M. C., Khan R. Baro D. J. (2008) Crustacean dopamine receptors: localization and G protein coupling in the stomatogastric ganglion. J. Neurochem. 104, 1006 1019.
14. Delsuc F., Brinkmann H., Chourrout D. Philippe H. (2006) Tunicates and not cephalochordates are the closest living relatives of vertebrates. Nature 439, 965 968.
15. Demchyshyn L. L., Sugamori K. S., Lee F. J., Hamadanizadeh S. A. Niznik H. B. (1995) The dopamine D1D receptor. Cloning and characterization of three pharmacologically distinct D1-like receptors from Gallus domesticus. J. Biol. Chem. 270, 4005 4012.
16. Drube S., Stirnweiss J., Valkova C. Liebmann C. (2006) Ligand-independent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling. Cell. Signal. 18, 1633 1646.
17. Eason M. G., Kurose H., Holt B. D., Raymond J. R. Liggett S. B. (1992) Simultaneous coupling of alpha 2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of alpha 2C10, alpha 2C4, and alpha 2C2 adrenergic receptors to Gi and Gs. J. Biol. Chem. 267, 15795 15801.
18. Evans P. D., Robb S., Cheek T. R., Reale V., Hannan F. L., Swales L. S., Hall L. M. Midgley J. M. (1995) Agonist-specific coupling of G-protein-coupled receptors to second-messenger systems. Prog. Brain Res. 106, 259 268.
19. Feng G., Hannan F., Reale V., Hon Y. Y., Kousky C. T., Evans P. D. Hall L. M. (1996) Cloning and functional characterization of a novel dopamine receptor from Drosophila melanogaster. J. Neurosci. 16, 3925 3933.
20. Frail D. E., Manelli A. M., Witte D. G., Lin C. W., Steffey M. E. Mackenzie R. G. (1993) Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization. Mol. Pharmacol. 44, 1113 1118.
21. Fujieda H., Scher J., Lukita-Atmadja W. Brown G. M. (2003) Gene regulation of melatonin and dopamine receptors during eye development. Neuroscience 120, 301 307.
22. Galandrin S. Bouvier M. (2006) Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Mol. Pharmacol. 70, 1575 1584.
23. Galandrin S., Oligny-Longpre G., Bonin H., Ogawa K., Gales C. Bouvier M. (2008) Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor. Mol. Pharmacol. 74, 162 172.
24. Giles H., Lansdell S. J., Bolofo M. L., Wilson H. L. Martin G. R. (1996) Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding. Br. J. Pharmacol. 117, 1119 1126.
25. Gothert M. (1985) Role of autoreceptors in the function of the peripheral and central nervous system. Arzneimittelforschung 35, 1909 1916.
26. Gotzes F., Balfanz S. Baumann A. (1994) Primary structure and functional characterization of a Drosophila dopamine receptor with high homology to human D1/5 receptors. Receptors Channels 2, 131 141.
27. Insel P. A. Ostrom R. S. (2003) Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell. Mol. Neurobiol. 23, 305 314.
28. Iredale P. A. Hill S. J. (1993) Increases in intracellular calcium via activation of an endogenous P2-purinoceptor in cultured CHO-K1 cells. Br. J. Pharmacol. 110, 1305 1310.
29. Kenakin T. (1995) Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16, 232 238.
30. Kenakin T. (2007) Functional selectivity through protean and biased agonism: who steers the ship? Mol. Pharmacol. 72, 1393 1401.
31. Le Crom S., Sugamori K. S., Sidhu A., Niznik H. B. Vernier P. (2004) Delineation of the conserved functional properties of D1A, D1B and D1C dopamine receptor subtypes in vertebrates. Biol. Cell 96, 383 394.
32. Luttrell L. M., Ferguson S. S., Daaka Y. et al. (1999) Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283, 655 661.
33. Mahan L. C., Burch R. M., Monsma F. J. Jr. Sibley D. R. (1990) Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes. Proc. Natl Acad. Sci. USA 87, 2196 2200.
34. Maqueira B., Chatwin H. Evans P. D. (2005) Identification and characterization of a novel family of Drosophila Beta-adrenergic-like octopamine G-protein coupled receptors. J. Neurochem. 94, 547 560.
35. Masu Y., Nakayama K., Tamaki H., Harada Y., Kuno M. Nakanishi S. (1987) cDNA cloning of bovine substance-K receptor through oocyte expression system. Nature 329, 836 838.
36. Missale C., Nash S. R., Robinson S. W., Jaber M. Caron M. G. (1998) Dopamine receptors: from structure to function. Physiol. Rev. 78, 189 225.
37. Moret F., Guilland J. C., Coudouel S., Rochette L. Vernier P. (2004) Distribution of tyrosine hydroxylase, dopamine, and serotonin in the central nervous system of amphioxus (Branchiostoma lanceolatum): implications for the evolution of catecholamine systems in vertebrates. J. Comp. Neurol. 468, 135 150.
38. Mustard J. A., Beggs K. T. Mercer A. R. (2005) Molecular biology of the invertebrate dopamine receptors. Arch. Insect Biochem. Physiol. 59, 103 117.
39. Nasman J., Kukkonen J. P. Akerman K. E. (2002) Dual signalling by different octopamine receptors converges on adenylate cyclase in Sf9 cells. Insect Biochem. Mol. Biol. 32, 285 293.
40. Neve K. A., Seamans J. K. Trantham-Davidson H. (2004) Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24, 165 205.
41. O'Boyle K. M., Gaitanopoulos D. E., Brenner M. Waddington J. L. (1989) Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor. Neuropharmacology 28, 401 405.
42. Olsson R., Yulis R. Rodriguez E. M. (1994) The infundibular organ of the lancelet (Branchiostoma lanceolatum, Acrania): an immunocytochemical study. Cell Tissue Res. 277, 107 114.
43. Pedersen U. B., Norby B., Jensen A. A., Schiodt M., Hansen A., Suhr-Jessen P., Scheideler M., Thastrup O. Andersen P. H. (1994) Characteristics of stably expressed human dopamine D1a and D1b receptors: atypical behavior of the dopamine D1b receptor. Eur. J. Pharmacol. 267, 85 93.
44. Putnam N. H., Butts T., Ferrier D. E. et al. (2008) The amphioxus genome and the evolution of the chordate karyotype. Nature 453, 1064 1071.
45. Rang H. P., Dale M. M. Ritter J. M. (1999) Pharmacology, 4th edn. Churchill Livingstone, Edinburgh.
46. Reale V., Hannan F., Hall L. M. Evans P. D. (1997) Agonist-specific coupling of a cloned Drosophila melanogaster D1-like dopamine receptor to multiple second messenger pathways by synthetic agonists. J. Neurosci. 17, 6545 6553.
47. Robb S., Cheek T. R., Hannan F. L., Hall L. M., Midgley J. M. Evans P. D. (1994) Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO J. 13, 1325 1330.
48. Rogers C., Reale V., Kim K., Chatwin H., Li C., Evans P. de Bono M. (2003) Inhibition of Caenorhabditis elegans social feeding by FMRFamide-related peptide activation of NPR-1. Nat. Neurosci. 6, 1178 1185.
49. Schmitt J. M. Stork P. J. (2002) PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1. Mol. Cell 9, 85 94.
50. Seabrook G. R., McAllister G., Knowles M. R., Myers J., Sinclair H., Patel S., Freedman S. B. Kemp J. A. (1994) Depression of high-threshold calcium currents by activation of human D2 (short) dopamine receptors expressed in differentiated NG108-15 cells. Br. J. Pharmacol. 111, 1061 1066.
51. Srivastava D. P., Yu E. J., Kennedy K., Chatwin H., Reale V., Hamon M., Smith T. Evans P. D. (2005) Rapid, nongenomic responses to ecdysteroids and catecholamines mediated by a novel Drosophila G-protein-coupled receptor. J. Neurosci. 25, 6145 6155.
52. Suo S., Sasagawa N. Ishiura S. (2002) Identification of a dopamine receptor from Caenorhabditis elegans. Neurosci. Lett. 319, 13 16.
53. Surmeier D. J., Bargas J., Hemmings H. C. Jr., Nairn A. C. Greengard P. (1995) Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 14, 385 397.
54. Swatton J. E., Sellers L. A., Faull R. L., Holland A., Iritani S. Bahn S. (2004) Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain. Eur. J. Neurosci. 19, 2711 2719.
55. Tang L., Todd R. D., Heller A. O'Malley K. L. (1994) Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268, 495 502.
56. Van Renterghem C., Bilbe G., Moss S., Smart T. G., Constanti A., Brown D. A. Barnard E. A. (1987) GABA receptors induced in Xenopus oocytes by chick brain mRNA: evaluation of TBPS as a use-dependent channel-blocker. Brain Res. 388, 21 31.
57. Vincent J. D., Cardinaud B. Vernier P. (1998) Evolution of monoamine receptors and the origin of motivational and emotional systems in vertebrates. Bull. Acad. Natl Med. 182, 1505 1516.
58. Wang C., Buck D. C., Yang R., Macey T. A. Neve K. A. (2005) Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases. J. Neurochem. 93, 899 909.
59. Weitl N. Seifert R. (2008) Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine. J. Pharmacol. Exp. Ther. 327, 760 769.
60. Wess J., Han S. J., Kim S. K., Jacobson K. A. Li J. H. (2008) Conformational changes involved in G-protein-coupled-receptor activation. Trends Pharmacol. Sci. 29, 616 625.
61. Williams P. J., MacVicar B. A. Pittman Q. J. (1989) A dopaminergic inhibitory postsynaptic potential mediated by an increased potassium conductance. Neuroscience 31, 673 681.
62. Xhaard H., Rantanen V. V., Nyrönen T. Johnson M. S. (2006) Molecular evolution of adrenoceptors and dopamine receptors: implications for the binding of catecholamines. J. Med. Chem. 49, 1706 1719.
63. Zhen X., Zhang J., Johnson G. P. Friedman E. (2001) D(4) dopamine receptor differentially regulates Akt/nuclear factor-kappa b and extracellular signal-regulated kinase pathways in D(4)MN9D cells. Mol. Pharmacol. 60, 857 864.